While India has started reporting less than 100,000 cases now—down from a peak of over 400,000—it surely isn’t out of the woods. There are multiple variants of coronavirus in the country, some more concerning than others. Meanwhile, as states start easing lockdowns, Indians are still wearing masks incorrectly and crowding. Experts have warned that a third wave is inevitable.

The biggest black spot for the country is its vaccination process. For one, there are massive supply constraints. Secondly, there are technical snags with the appointment booking platform. Then, the distribution of vaccines has changed hands from central to state governments and back to the centre, with many hiccups. On top of all these missteps, vaccine pricing has been another point of contention.

In fact, the vaccination plans of several of its neighbours have been crippled because of India. Pakistan, Nepal, and Bangladesh were among the 91 countries that faced shortages after India halted exports of vaccines manufactured by the Serum Institute of India in March.

Other channels like the World Health Organisation’s Covax programme for low-income countries have been inefficient, too. For instance, Afghanistan was due to receive three million doses from this route in April, but they won’t arrive until August.

📬 Sign up for the Daily Brief

Our free, fast, and fun briefing on the global economy, delivered every weekday morning.